All Stories

  1. Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022

    Article • Clinical Rheumatology, April 2024, Springer Science + Business Media

    Dr Hedley Griffiths

  2. Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost‐savings

    Article • Internal Medicine Journal, November 2023, Wiley

    Dr Hedley Griffiths

  3. Dr. Griffiths et al reply

    Article • The Journal of Rheumatology, May 2022, The Journal of Rheumatology

    Dr Hedley Griffiths

  4. Prevalence of sleep disturbance and the association between poor disease control in people with ankylosing spondylitis within the Australian clinical setting (ASLEEP study): a real-world observational study using the OPAL dataset

    Article • Clinical Rheumatology, November 2021, Springer Science + Business Media

    Dr Hedley Griffiths

  5. Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia

    Article • Clinical Rheumatology, August 2021, Springer Science + Business Media

    Dr Hedley Griffiths

  6. Persistence to Biologic Therapy Among Patients With Ankylosing Spondylitis: An Observational Study Using the OPAL Dataset

    Article • The Journal of Rheumatology, August 2021, The Journal of Rheumatology

    Dr Hedley Griffiths

  7. Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia

    Article • Clinical Rheumatology, March 2020, Springer Science + Business Media

    Dr Hedley Griffiths

  8. Reasons for Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drug Cessation and Persistence of Second-line Treatment in a Rheumatoid Arthritis Dataset

    Article • The Journal of Rheumatology, December 2019, The Journal of Rheumatology

    Dr Hedley Griffiths

  9. assessing very early dynamic changes in joint structure in RA

    Article • International Journal of Rheumatology, January 2018, Hindawi Publishing Corporation

    Dr Hedley Griffiths

  10. The CEDAR Study: A Longitudinal Study of the Clinical Effects of Conventional DMARDs and Biologic DMARDs in Australian Rheumatology Practice

    Article • International Journal of Rheumatology, January 2017, Hindawi Publishing Corporation

    Professor Geoffrey Owen Littlejohn, Dr Hedley Griffiths